Lv5
1000 积分 2024-09-22 加入
Scalable Electro‐Biosynthesis of Ectoine from Greenhouse Gases
4个月前
已完结
Drug Design of GLP-1 Receptor Agonists: Importance of In Silico Methods
5个月前
已完结
The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines
5个月前
已完结
The Discovery and Development of Ruxolitinib for the Treatment of Myelofibrosis
6个月前
已关闭
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
6个月前
已完结
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
7个月前
已完结
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
7个月前
已完结
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
7个月前
已完结
Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice
7个月前
已完结
The unexpected role of GIP in transforming obesity treatment
7个月前
已完结
皖公网安备34019202002308
